Cargando…
Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging
BACKGROUND: In this study, a novel pelvic phantom was developed and used to assess the visibility and presence of artefacts from different types of commercial fiducial markers (FMs) on multi-modality imaging relevant to prostate cancer. METHODS AND MATERIALS: The phantom was designed with 3D printed...
Autores principales: | Osman, Sarah O. S., Russell, Emily, King, Raymond B., Crowther, Karen, Jain, Suneil, McGrath, Cormac, Hounsell, Alan R., Prise, Kevin M., McGarry, Conor K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933910/ https://www.ncbi.nlm.nih.gov/pubmed/31878967 http://dx.doi.org/10.1186/s13014-019-1447-1 |
Ejemplares similares
-
An overview of current practice in external beam radiation oncology with consideration to potential benefits and challenges for nanotechnology
por: King, Raymond B., et al.
Publicado: (2017) -
A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
por: Lyons, Ciara A., et al.
Publicado: (2017) -
Small field dosimetry for the small animal radiotherapy research platform (SARRP)
por: Ghita, Mihaela, et al.
Publicado: (2017) -
Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers
por: Osman, Sarah O. S., et al.
Publicado: (2022) -
Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life
por: Osman, Sarah O. S., et al.
Publicado: (2017)